- Home
- SFHG vs ESPR Comparison
SFHG vs ESPR Comparison
Compare SFHG & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- ESPR
- Stock Information
- Founded
- SFHG 1993
- ESPR 2008
- Country
- SFHG Hong Kong
- ESPR United States
- Employees
- SFHG N/A
- ESPR N/A
- Industry
- SFHG Publishing
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- SFHG Consumer Discretionary
- ESPR Health Care
- Exchange
- SFHG Nasdaq
- ESPR Nasdaq
- Market Cap
- SFHG 17.3M
- ESPR 305.0M
- IPO Year
- SFHG 2024
- ESPR 2013
- Fundamental
- Price
- SFHG $0.77
- ESPR $1.67
- Analyst Decision
- SFHG
- ESPR Buy
- Analyst Count
- SFHG 0
- ESPR 7
- Target Price
- SFHG N/A
- ESPR $6.36
- AVG Volume (30 Days)
- SFHG 144.2K
- ESPR 4.2M
- Earning Date
- SFHG 12-20-2024
- ESPR 03-04-2025
- Dividend Yield
- SFHG N/A
- ESPR N/A
- EPS Growth
- SFHG N/A
- ESPR N/A
- EPS
- SFHG 0.01
- ESPR N/A
- Revenue
- SFHG $19,005,455.00
- ESPR $332,314,000.00
- Revenue This Year
- SFHG N/A
- ESPR $5.51
- Revenue Next Year
- SFHG N/A
- ESPR $1.42
- P/E Ratio
- SFHG $88.03
- ESPR N/A
- Revenue Growth
- SFHG 31.66
- ESPR 185.66
- 52 Week Low
- SFHG $0.55
- ESPR $1.47
- 52 Week High
- SFHG $24.00
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- SFHG N/A
- ESPR 48.04
- Support Level
- SFHG N/A
- ESPR $1.47
- Resistance Level
- SFHG N/A
- ESPR $1.61
- Average True Range (ATR)
- SFHG 0.00
- ESPR 0.13
- MACD
- SFHG 0.00
- ESPR 0.01
- Stochastic Oscillator
- SFHG 0.00
- ESPR 51.28
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.